Assays

#Antibody #Antibody reagents #Assays

Exclusive DDW event: generate and validate critical antibody reagents

Antibodies are critical reagents applied in multiple biological areas, such as scientific research, therapeutics, and diagnosis. High-quality and reliable antibody reagents are the foundation of good assay performance. To learn more generating and validating critical antibody reagents join this free event hosted by DDW and supported by Sino Biological. It… Read More

#News

#Antibodies #Antibody reagents #Assays

Learn how to generate and validate critical antibody reagents

Antibodies are critical reagents applied in multiple biological areas, such as scientific research, therapeutics, and diagnosis. High-quality and reliable antibody reagents are the foundation of good assay performance. To learn more generating and validating critical antibody reagents join this free event hosted by DDW and supported by Sino Biological. It… Read More

#News

#Antibodies #Antibody reagents #Assays #Therapeutics

Generating and validating critical antibody reagents: event

Antibodies are critical reagents applied in multiple biological areas, such as scientific research, therapeutics, and diagnosis. High-quality and reliable antibody reagents are the foundation of good assay performance. To learn more generating and validating critical antibody reagents join this free event hosted by DDW and supported by Sino Biological. It… Read More

#News

#Assays #Biopharmaceuticals #Biotherapeutics #Drug development #Drug discovery

PerkinElmer releases assay kits for more effective biotherapeutics 

PerkinElmer has announced two ready-to-use HTRF and AlphaLISA no-wash assay kits designed to quickly and easily detect and quantify CHO HCP impurities during biopharmaceutical manufacturing.   Recombinant therapeutic proteins, such as monoclonal antibodies, some vaccines and other biologics, must be free of residual host cell protein (HCP) impurities… Read More

#News

#Assays #Reagents

Multiomics assay speeds discovery in immunologic diseases 

Medical technology company BD has recently released the BD Rhapsody TCR/BCR Multiomic Assay, a set of reagents that enables researchers to more easily and comprehensively analyse cells, providing a tool to advance research in autoimmune disorders, immuno-oncology and infectious diseases.   The multiomic assay supplies immunology researchers the… Read More

#News

#Assays #Drug discovery

Domainex supports growth with investment 

Domainex has purchased over £1 million worth of new Waters equipment to enhance its capabilities in analytical chemistry, bioanalytical sciences and in vitro absorbance, distribution, metabolism and excretion (ADME) assays. The company says the equipment will allow Domainex to increase its capacity and throughput, supporting its ongoing growth. … Read More

#News

#Assays #Genetics / genomics #Genome sequencing

Genome sequencing assays for infectious disease surveillance

"Viruses evolve — that’s a fact of life", says Dr Nick Downey (NGS collaborations lead, Integrated DNA Technologies), Dr Nikki Freed (Auckland Genomics, University of Auckland, New Zealand) and Dr Olin Silander (School of Natural and Computational Sciences, Massey University, New Zealand) in this DDW exclusive. Every time a virus replicates itself, there… Read More

#Editor's Choice #Exclusive Content #News

#Antibodies #Assays

App Note explains the power of anti-idiotype antibodies

Assessing the safety and efficacy of biotherapeutics is imperative during the drug-development process. In particular, pharmacokinetic (PK) and anti-drug antibody (ADA) assays are conducted to study and evaluate new drug candidates and biosimilars. For PK/ADA assays, anti-idiotype antibodies (Anti-IDs) are powerful tools to measure the concentration of antibody drugs in… Read More

#News #Trending News

#Assays #Biotechnology #Drug discovery #Enzymes #TechNote

TechNote: Radioactivity assays for methyltransferase enzymes

In this free TechNote by SAMDI Tech, learn how the company’s radioactivity assays overcome key challenges in drug discovery by offering key solutions, including: Detecting low amounts of product with sensitive assays Generating data rapidly with high-throughput, 384-well capabilities Characterising potent inhibitors by benefiting from lower enzyme concentrations Learn… Read More

#News #Trending News

#Assays #Mass spectrometry / NMR #Webinar

Webinar: Bioanalytical assay development using LC-MS/MS

A free webinar, Sensitive signature peptide quantification using accurate mass spectrometry, was hosted by DDW on December 1, 2021, at 4PM GMT, 9AM PT; 12PM ET; 5PM CET. It was supported by SCIEX.   Emerging advancements in protein biotherapeutics are driving the… Read More

#News

#Assays #Biotechnology #Cell and gene therapy #Cell therapy #iPSC

Ncardia secures $60+ million for its iPSC Offerings 

Ncardia, developer of stem cell-based solutions for drug discovery and cell therapy, has secured more than $60 million in capital through a strategic partnership with Kiniciti, a US-based investment platform.  Ncardia’s capabilities include bio-reactor-based scalable manufacturing of iPSC derived cells, assay development, disease modeling, and cell-based screening. … Read More

#News

#Assays #Biotherapeutics #Drug targets #Mass spectrometry / NMR #Webinar

The challenges of peptide and protein quantification: Webinar

The importance of biotherapeutics as a class of drugs continues to increase. Indeed, their low toxicity and high specificity justify their investigation as drug candidates. Yet, quantification studies of biotherapies in complex biological matrices can be very challenging. In particular, high background noise and interferences due to endogenous proteins… Read More

#News

#Assays #Drug targets #Mass spectrometry / NMR #Webinar

The steps to developing a quantitative assay for signature peptides 

Sensitive signature peptide quantification using accurate mass spectrometry is a free webinar that was hosted by DDW on December 1, 2021, at 4PM GMT, 9AM PT; 12PM ET; 5PM CET. It was supported by SCIEX.  Dr. Xin Zhang, Senior Application Scientist at SCIEX, presented… Read More

#News

#Assays #Blood cancer #Cancer research

SAGA Diagnostics and AstraZeneca enter assay development agreement

SAGA Diagnostics, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, has entered into an assay development agreement with Astra Zeneca to develop SAGAsafe dPCR assays towards undisclosed methylated targets for analyses of tissue samples and liquid biopsies.   James Hadfield,… Read More

#News